Drug Shortage Report for ACETYLCYSTEINE SOLUTION USP
Report ID | 171228 |
Drug Identification Number | 02459906 |
Brand name | ACETYLCYSTEINE SOLUTION USP |
Common or Proper name | ACETYLCYSTEINE SOLUTION USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ACETYLCYSTEINE |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL INTRAVENOUS INHALATION ORAL INTRAVENOUS INHALATION |
Packaging size | 30ML |
ATC code | R05CB |
ATC description | EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-10-06 |
Estimated end date | 2023-01-20 |
Actual end date | 2023-01-20 |
Shortage status | Resolved |
Updated date | 2023-06-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2023-06-02 | English | Compare |
v15 | 2023-01-24 | French | Compare |
v14 | 2023-01-24 | English | Compare |
v13 | 2023-01-16 | French | Compare |
v12 | 2023-01-16 | English | Compare |
v11 | 2023-01-09 | French | Compare |
v10 | 2023-01-09 | English | Compare |
v9 | 2022-12-30 | French | Compare |
v8 | 2022-12-30 | English | Compare |
v7 | 2022-11-18 | English | Compare |
v6 | 2022-11-03 | French | Compare |
v5 | 2022-11-03 | English | Compare |
v4 | 2022-10-07 | English | Compare |
v3 | 2022-10-06 | French | Compare |
v2 | 2022-10-06 | English | Compare |
v1 | 2022-10-06 | English | Compare |
Showing 1 to 16 of 16